eujobs.coEU jobs in brussels
Post a JobHeadhunter

Cancer Research UK

Acronym: CRUK

General Information

Identification Code: 54970512687-47
Website: [object Object]
Entity Form: NGO
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 12/1/2009
Last Update: 2/7/2024
EP Accredited Number: 0

Mission & Interests

Goals: Cancer Research UK is the world’s leading cancer charity, dedicated to saving and improving lives through our research, influence and information. We’re the largest charitable funder of cancer research in the world, funding around 50% of all publicly funded cancer research in the UK. https://www.cancerresearchuk.org/sites/default/files/cruk_annual_report_accounts_2022-2023.pdf In 2022/23, we spent £415m on new and ongoing research. Our network of centres and institutes are where more than 4,000 scientists, doctors and nurses work together to help us beat cancer, carrying out everything from laboratory studies to large-scale clinical trials. Through programmes like Cancer Grand Challenges, we bring together a worldwide network of leading scientists from across the globe to carry out groundbreaking research. We also work with other research funders, cancer societies and governments around the world to pool our resources and knowledge to accelerate progress towards beating cancer.
Interests Represented: Does not represent commercial interests
Interests:
  • International co-operation and development
  • Public health
  • Research and innovation
Levels of Interest:
  • national
  • global
  • sub-national
  • european

Activities

Main EU Legislative Proposals: UK-EU relations, UK Data Adequacy, Clinical Trial Regulation, Horizon Europe, tobacco control and other public health potentially including obesity in future; potentially the Orphan & Paediatric Medicines Regulations and the Pharmaceutical Regulation. EU Cancer Plan in general.
Communication Activities: Attend events aimed at the cancer, health and science policy communities at which EU officials can be present (e.g. European Health Forum Gastein, 2023). Participation in EU-facing coalition/org meetings and activities at which EU officials can be present (e.g. the European Cancer Organisation's European Cancer Summit 2023). In the past, CRUK has held a meetings programme including EU officials and elected politicians, and we intend to do so again in future, as appropriate to the UK's new relationship with the EU. Potentially CRUK/joint articles for European media.
Inter-institutional or Unofficial Groupings: Cancer

Head Office

Address: 2 Redman Place
Post Code: E20 1JQ
City: London
Country: UNITED KINGDOM
Phone: [object Object]

EU Office

Address: 2 Redman Place
Post Code: E20 1JQ
City: London
Country: UNITED KINGDOM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: For a list of benefactors, major supporters, major trusts and foundations, corporate partners and other donation information, please see CRUK's annual report and accounts https://www.cancerresearchuk.org/about-us/our-organisation/how-we-spend-your-money In 2022/23, our income was a total of £718.8 million (840 million EUR using exchange rate on 5 February 2024 xe.com). In 2022/23, our annual expenditure was £641m (749 million EUR). This includes: • £398m committed to research • £27m on information and influencing work • £109m raising donated income and managing our investments • £107m running our shops and other trading activity. In 2022/23, we spent £415m on new and ongoing research. This includes: £176m on research projects focused on specific cancer types £89m relevant to all types of cancer (eg research infrastructure and research studies looking at cancer survivorship) £83m on basic research understanding the fundamental biology of cancer £40m on research admin and support costs (eg peer review, grant management, IT and other support costs) £27m on revenue shares (share of royalties from sales of innovations developed from our research, which we passed on to others) In 2022/23, we spent £18.7m on research specific to cancers that affect 0–24-year-olds, making us the UK's biggest charitable funder of research into children’s and young people’s cancers. For more information please see: https://www.cancerresearchuk.org/about-us/our-organisation/how-we-spend-your-money

Membership Information

Members10 Percent: 0
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 1
Members: 1
Members F T E: 0.75
Info Members: 0.8 Full-time equivalent in the Europe & Global Affairs Manager role. Some policy development support. Occasional involvement by other staff across the organisation. CRUK Trustee, Professor Pamela Kearns, is involved in conversations about the EU pharmaceutical legislation in her role as Past President of the European Society for Paediatric Oncology (SIOPE) e.g. https://siope.eu/media/documents/1final-programme-mac-siope-gold-sept-2023.pdf https://www.cancerresearchuk.org/about-us/how-we-are-run/our-trustees

Structure

Structure Type: Structure
Is Member Of: We have over 150 research partnerships worldwide https://www.cancerresearchuk.org/funding-for-researchers/ - including the US, French and Dutch government-funded cancer institutes (Cancer Grand Challenges). We have relationships and policy partnerships with other cancer societies around the world including across the EU. See also the list above. We would be happy to expand if needed. Cancer Research Horizons joined the PRIME-ROSE project in 2023, which is funded by Horizon Europe https://www.cancerresearchhorizons.com/news/cancer-research-uk-joins-european-precision-cancer-medicine-trial-consortium It is very likely that individual CRUK-funded researchers (some in CRUK-funded institutes) have now applied for European Research Council grants for Horizon Europe collaborations.
Organisation Members: We are a paying member of or work jointly with many associations/networks etc, including the Cancer Grand Challenges https://cancergrandchallenges.org/, European Organisation for Research and Treatment of Cancer (EORTC), International Cancer Benchmarking Partnership, Cancer Prevention Europe (CPE - led by IARC) European Public Health Alliance (EPHA), the Smoke Free Partnership (SFP), the Union for International Cancer Control (UICC), the Federation of European Academies of Medicine (FEAM), Association of European Cancer Leagues (ECL), the European Cancer Organisation (ECO), Global Alliance for Tobacco Control (GATC), NCD Alliance (NCDA), G7 Cancer initiative, International Cancer Research Partnership (ICRP). We would be happy to expand if needed.